Clinical assessment on treatment of hyperlipidemia with pushen capsule.
- Author:
Zong-lian LIU
1
;
Sheng-xian WU
;
Gai-di GAO
Author Information
- Publication Type:Clinical Trial
- MeSH: Adult; Aged; Blood Viscosity; Capsules; Cholesterol, HDL; blood; Cholesterol, LDL; blood; Double-Blind Method; Drugs, Chinese Herbal; therapeutic use; Female; Humans; Hyperlipidemias; drug therapy; Hypolipidemic Agents; therapeutic use; Male; Middle Aged; Phytotherapy; Prospective Studies; Triglycerides; blood
- From: Chinese Journal of Integrated Traditional and Western Medicine 2004;24(3):227-229
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo explore the therapeutic effect of Pushen capsule (PSC) in treating primary hyperlipidemia.
METHODSTwo hundred and forty patients with primary hyperlipidemia were randomly divided into two groups, the 120 patients in the treated group treated with PSC (4 capsules, tid) and the 120 patients in the control group treated with Zhibituo tablet (3 tablets, tid), and they were administered at the same time with Zhibituo placebo. The therapeutic course for both groups was 4 weeks. The therapeutic effect and the effects on blood lipids and viscosity were observed.
RESULTSThe effective rate in the treated group was 76.3%, which was significantly higher than that in the control group (48.7%, P < 0.01). PSC showed a significant lowering effect on TC, TG and LDL-C and raising effect on HDL-C, and the effect in lowering TG was significantly better than that of Zhibituo (P < 0.01). PSC also showed a certain effect in decreasing whole blood viscosity of both high-sheared and low-sheared viscosity.
CONCLUSIONPushen capsule has promising blood lipid regulating effect in patients with hyperlipidemia, and some effects in lowering the blood viscosity.
